Prevalence of self-reported cardiovascular disease among persons aged > or =35 years with diabetes--United States, 1997-2005
- PMID: 17975525
Prevalence of self-reported cardiovascular disease among persons aged > or =35 years with diabetes--United States, 1997-2005
Abstract
Adults with diabetes are at greater risk for dying from heart disease than adults without diabetes. Heart disease and stroke account for approximately 65% of deaths among persons with diabetes. During 1997-2005, the age-adjusted prevalence of diagnosed diabetes in the United States increased 43%, from 3.7% in 1997 to 5.3% in 2005. To assess trends in prevalence of heart disease, stroke, and other cardiovascular diseases (CVDs) among persons with diabetes, CDC analyzed data from the National Health Interview Survey (NHIS). This report summarizes the results of that assessment, which indicated that although the number of persons aged > or =35 years with diagnosed diabetes who reported having CVD increased 36% during 1997-2005, the age-adjusted prevalence decreased 11%; however, the decrease in CVD prevalence did not occur in all subpopulations with diabetes. The decrease in CVD prevalence indicates that the increase in the number of persons with diagnosed diabetes exceeded the increase in the number of persons with diagnosed diabetes who reported having a CVD. Continued interventions are needed to reduce modifiable CVD risk factors among persons with diabetes, better control diabetes, and decrease CVD prevalence further.
Similar articles
-
Major cardiovascular disease (CVD) during 1997-1999 and major CVD hospital discharge rates in 1997 among women with diabetes--United States.MMWR Morb Mortal Wkly Rep. 2001 Nov 2;50(43):948-54. MMWR Morb Mortal Wkly Rep. 2001. PMID: 11708592
-
Self-reported heart disease and stroke among adults with and without diabetes--United States, 1999-2001.MMWR Morb Mortal Wkly Rep. 2003 Nov 7;52(44):1065-70. MMWR Morb Mortal Wkly Rep. 2003. PMID: 14603181
-
Self-reported visual impairment among persons with diagnosed diabetes --- United States, 1997--2010.MMWR Morb Mortal Wkly Rep. 2011 Nov 18;60(45):1549-53. MMWR Morb Mortal Wkly Rep. 2011. PMID: 22089967
-
Epidemiologic perspectives of risk for developing diabetes and diabetes complications.Nurs Clin North Am. 2006 Dec;41(4):487-98, v. doi: 10.1016/j.cnur.2006.07.008. Nurs Clin North Am. 2006. PMID: 17059970 Review.
-
Cardiovascular disease prevalence and risk factors of persons with mental retardation.Ment Retard Dev Disabil Res Rev. 2006;12(1):3-12. doi: 10.1002/mrdd.20095. Ment Retard Dev Disabil Res Rev. 2006. PMID: 16435328 Review.
Cited by
-
Diabetes and sepsis outcomes--it is not all bad news.Crit Care. 2009;13(1):117. doi: 10.1186/cc7707. Epub 2009 Feb 18. Crit Care. 2009. PMID: 19291261 Free PMC article. Review.
-
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.Circulation. 2017 Mar 7;135(10):e146-e603. doi: 10.1161/CIR.0000000000000485. Epub 2017 Jan 25. Circulation. 2017. PMID: 28122885 Free PMC article. Review. No abstract available.
-
Incretin-based therapies: focus on effects beyond glycemic control alone.Diabetes Ther. 2013 Dec;4(2):221-38. doi: 10.1007/s13300-013-0040-0. Epub 2013 Sep 21. Diabetes Ther. 2013. PMID: 24057947 Free PMC article.
-
Effect of Ranolazine Monotherapy on Glycemic Control in Subjects With Type 2 Diabetes.Diabetes Care. 2015 Jul;38(7):1189-96. doi: 10.2337/dc14-2629. Epub 2015 Jun 6. Diabetes Care. 2015. PMID: 26049552 Free PMC article. Clinical Trial.
-
Efficacy and safety of canagliflozin in patients with type 2 diabetes based on history of cardiovascular disease or cardiovascular risk factors: a post hoc analysis of pooled data.Cardiovasc Diabetol. 2017 Mar 21;16(1):40. doi: 10.1186/s12933-017-0517-7. Cardiovasc Diabetol. 2017. PMID: 28327140 Free PMC article. Clinical Trial.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical